Skip to main content

Table 7 Results of survival analysis in the primary cohort: grouping by predictive factors

From: Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study

 

Median DFS (months)

95% CI

p value

T1WI_NGTDM_Strength

  

0.006

 Low-T1WI_NGTDM_Strength (n = 10)

5.1

2.0–8.2

 

 High-T1WI_NGTDM_Strength (n = 21)

13.0

4.5–21.5

 

Tumour location

  

0.016

 Pancreatic head (n = 15)

7.0

6.2–7.8

 

 Pancreatic neck, body, and tail (n = 16)

20.0

0.0–40.2

 

Total (n = 31)

10.7

5.7–15.7

 
  1. Bold means statistically significant (p values < 0.05)